Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1960 1
1962 1
1963 1
1964 3
1965 1
1973 1
1974 1
1975 2
1976 3
1977 4
1978 1
1980 10
1981 4
1982 2
1983 3
1984 6
1985 6
1986 14
1987 9
1988 14
1989 11
1990 20
1991 17
1992 22
1993 22
1994 37
1995 36
1996 35
1997 41
1998 47
1999 48
2000 73
2001 99
2002 80
2003 121
2004 116
2005 184
2006 223
2007 262
2008 370
2009 388
2010 468
2011 593
2012 664
2013 800
2014 959
2015 1057
2016 1100
2017 1317
2018 1601
2019 1763
2020 2140
2021 2548
2022 3002
2023 2873
2024 1383

Text availability

Article attribute

Article type

Publication date

Search Results

21,955 results

Results by year

Filters applied: . Clear all
Page 1
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study.
Qin S, Chan SL, Gu S, Bai Y, Ren Z, Lin X, Chen Z, Jia W, Jin Y, Guo Y, Hu X, Meng Z, Liang J, Cheng Y, Xiong J, Ren H, Yang F, Li W, Chen Y, Zeng Y, Sultanbaev A, Pazgan-Simon M, Pisetska M, Melisi D, Ponomarenko D, Osypchuk Y, Sinielnikov I, Yang TS, Liang X, Chen C, Wang L, Cheng AL, Kaseb A, Vogel A; CARES-310 Study Group. Qin S, et al. Among authors: yang f. Lancet. 2023 Sep 30;402(10408):1133-1146. doi: 10.1016/S0140-6736(23)00961-3. Epub 2023 Jul 24. Lancet. 2023. PMID: 37499670 Clinical Trial.
Safety and efficacy of three enteral feeding strategies in patients with severe stroke in China (OPENS): a multicentre, prospective, randomised, open-label, blinded-endpoint trial.
Zhao J, Yuan F, Song C, Yin R, Chang M, Zhang W, Zhang B, Yu L, Jia Y, Ma Y, Song Y, Wang C, Song C, Wang X, Shang L, Yang F, Jiang W; OPENS Trial Investigators. Zhao J, et al. Among authors: yang f. Lancet Neurol. 2022 Apr;21(4):319-328. doi: 10.1016/S1474-4422(22)00010-2. Epub 2022 Feb 24. Lancet Neurol. 2022. PMID: 35219379 Clinical Trial.
Ciprofol-associated Pink Urine.
Xu L, Yang F, Zhu X, Wei P. Xu L, et al. Among authors: yang f. Eur J Anaesthesiol. 2024 Jun 1;41(6):460-461. doi: 10.1097/EJA.0000000000001916. Epub 2024 May 8. Eur J Anaesthesiol. 2024. PMID: 38690589 Free PMC article. No abstract available.
Crystallization-induced emission from F-doped carbon dots.
Guo T, Yang G, Li Y, Liu C, Yang F, Hou D, Sun H, Zheng Y, Lin X, Liu L. Guo T, et al. Among authors: yang f. Nanoscale Adv. 2024 Mar 27;6(8):1997-2001. doi: 10.1039/d4na00206g. eCollection 2024 Apr 16. Nanoscale Adv. 2024. PMID: 38633051 Free PMC article.
Role of the gut microbiota in tumorigenesis and treatment.
Liu Q, Yang Y, Pan M, Yang F, Yu Y, Qian Z. Liu Q, et al. Among authors: yang f. Theranostics. 2024 Mar 17;14(6):2304-2328. doi: 10.7150/thno.91700. eCollection 2024. Theranostics. 2024. PMID: 38646653 Free PMC article. Review.
Impurity study of tecovirimat.
Bonku EM, Qin H, Odilov A, Abduahadi S, Desta Guma S, Yang F, Xing X, Wang X, Shen J. Bonku EM, et al. Among authors: yang f. Heliyon. 2024 May 2;10(9):e29559. doi: 10.1016/j.heliyon.2024.e29559. eCollection 2024 May 15. Heliyon. 2024. PMID: 38742068 Free PMC article.
Coronary hemodynamic simulation study.
Cheng L, Chen Z, Yang F, Zheng R, He W, Shi F, Liu C, Wang F, Wang L, Xie Y, Lu H. Cheng L, et al. Among authors: yang f. Proc Inst Mech Eng H. 2024 Apr;238(4):444-454. doi: 10.1177/09544119241231028. Epub 2024 Mar 19. Proc Inst Mech Eng H. 2024. PMID: 38503717
21,955 results
You have reached the last available page of results. Please see the User Guide for more information.